🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether atazanavir powder combine...
Status
Completed
Location
Local Institution
Start Date
2010-10-13
Trial ID
NCT01099579
Treatments Being Tested
This is a retrospective review of data documented in medical records....
Status
Completed
Location
Children's Center for Rehabilitation Hospital
Start Date
2018-06-15
Trial ID
NCT03497091
Treatments Being Tested
The proposed study represents the first attempt to systematically investiga...
Status
Completed
Location
Marcus Autism Center - Children's Healthcare of Atlanta
Start Date
2013-03
Trial ID
NCT01923896
Treatments Being Tested
The investigators primary objective is to acquire preliminary data on one-h...
Status
Completed
Location
Amen Clinics, Inc.
Start Date
2009-05
Trial ID
NCT01515839
Treatments Being Tested
This is a double blind placebo controlled clinical study designed to determ...
Status
Completed
Location
Rockefeller University Hospital
Start Date
2001-03
Trial ID
NCT00050791
Treatments Being Tested
The purpose of this clinical trial is to identify the infant formula(s) for...
Status
Completed
Location
Department of Pediatrics
Start Date
2009-09
Trial ID
NCT00984230
Treatments Being Tested
To assess the 1-month effects and safety of esketamine combined PRF and sta...
Status
Recruiting
Location
Beijing Tiantan Hospital
Start Date
2025-04-01
Trial ID
NCT06890897
Treatments Being Tested
To prevent portal vein thrombosis (PVT) in patients with cirrhosis at risk ...
Status
Withdrawn
Location
Penn State College of Medicine
Start Date
2021-01-01
Trial ID
NCT04055389
Treatments Being Tested
Corticosteroids, intravenous immunoglobulin (IVIG), and plasma exchange (PE...
Status
Completed
Location
Xuanwu Hospital of Capital Medical University
Start Date
2020-11-25
Trial ID
NCT03542279
This is a Phase II, open label, randomized study of durvalumab in combinati...
Status
Terminated
Location
Huntsman Cancer Institute at University of Utah
Start Date
2020-06-18
Trial ID
NCT04163432
Treatments Being Tested